Šuštić, Tonći
van Wageningen, Sake
Bosdriesz, Evert
Reid, Robert J. D.
Dittmar, John
Lieftink, Cor
Beijersbergen, Roderick L.
Wessels, Lodewyk F. A.
Rothstein, Rodney
Bernards, René
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Rubicon)
KWF Kankerbestrijding (N/A)
New York State Department of Health (HRSB-C028248)
National Cancer Institute (R33 CA125520, T32 CA009503)
National Institute of General Medical Sciences (R35 GM118180)
Article History
Received: 13 August 2018
Accepted: 13 November 2018
First Online: 27 November 2018
Change Date: 10 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13073-020-00815-5
Authors’ information
: RLB is an associate professor at the Division of Molecular Carcinogenesis and the head of High Content Screening Facility at the Netherlands Cancer Institute. LW is a professor of Computational Cancer Biology at the Technical University in Delft and the co-director of the Cancer Systems Biology Center at the Netherlands Cancer Institute. RJDR is a Research Associate in the Department of Genetics & Development at Columbia University Vagelos College of Physicians & Surgeons. RR is a professor of Genetics & Development and Systems Biology at Columbia University Vagelos College of Physicians & Surgeons. RB is a professor of Molecular Carcinogenesis at the Netherlands Cancer Institute.
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.